Gå videre til innholdet
  • Butikk
    • Se alt
    • Enheter
      • CAROL Bike
      • Agen Band
      • Agen Robot
      • Sammenlign enheter
    • Handle etter mål
      • Heart
      • Mood & focus
      • Rest
      • Performance
      • Digestion
      • Skin & hair
      • Vitality
    • Pakker & planer
      • Daily longevity bundle
      • Executive focus kit
      • Peak recovery stack
      • Medlemskap
  • App
  • Slik fungerer det
  • Vitenskap
  • Journal
  • Partnere

Språk

  • Butikk
    • Se alt
    • Enheter
    • Handle etter mål
    • Pakker & planer
  • App
  • Slik fungerer det
  • Vitenskap
  • Journal
  • Partnere
  • Country/Region

      Fant ingen resultater
    • Afghanistan AFN ؋
    • Åland Islands EUR €
    • Albania ALL L
    • Algeria DZD د.ج
    • Andorra EUR €
    • Angola USD $
    • Anguilla XCD $
    • Antigua & Barbuda XCD $
    • Argentina USD $
    • Armenia AMD դր.
    • Aruba AWG ƒ
    • Ascension Island SHP £
    • Australia AUD $
    • Austria EUR €
    • Azerbaijan AZN ₼
    • Bahamas BSD $
    • Bahrain USD $
    • Bangladesh BDT ৳
    • Barbados BBD $
    • Belarus USD $
    • Belgium EUR €
    • Belize BZD $
    • Benin XOF Fr
    • Bermuda USD $
    • Bhutan USD $
    • Bolivia BOB Bs.
    • Bosnia & Herzegovina BAM КМ
    • Botswana BWP P
    • Brazil USD $
    • British Indian Ocean Territory USD $
    • British Virgin Islands USD $
    • Brunei BND $
    • Bulgaria EUR €
    • Burkina Faso XOF Fr
    • Burundi BIF Fr
    • Cambodia KHR ៛
    • Cameroon XAF CFA
    • Canada CAD $
    • Cape Verde CVE $
    • Caribbean Netherlands USD $
    • Cayman Islands KYD $
    • Central African Republic XAF CFA
    • Chad XAF CFA
    • Chile USD $
    • China CNY ¥
    • Christmas Island AUD $
    • Cocos (Keeling) Islands AUD $
    • Colombia USD $
    • Comoros KMF Fr
    • Congo - Brazzaville XAF CFA
    • Congo - Kinshasa CDF Fr
    • Cook Islands NZD $
    • Costa Rica CRC ₡
    • Côte d’Ivoire XOF Fr
    • Croatia EUR €
    • Curaçao ANG ƒ
    • Cyprus EUR €
    • Czechia CZK Kč
    • Denmark DKK kr.
    • Djibouti DJF Fdj
    • Dominica XCD $
    • Dominican Republic DOP $
    • Ecuador USD $
    • Egypt EGP ج.م
    • El Salvador USD $
    • Equatorial Guinea XAF CFA
    • Eritrea USD $
    • Estonia EUR €
    • Eswatini USD $
    • Ethiopia ETB Br
    • Falkland Islands FKP £
    • Faroe Islands DKK kr.
    • Fiji FJD $
    • Finland EUR €
    • France EUR €
    • French Guiana EUR €
    • French Polynesia XPF Fr
    • French Southern Territories EUR €
    • Gabon XOF Fr
    • Gambia GMD D
    • Georgia USD $
    • Germany EUR €
    • Ghana USD $
    • Gibraltar GBP £
    • Greece EUR €
    • Greenland DKK kr.
    • Grenada XCD $
    • Guadeloupe EUR €
    • Guatemala GTQ Q
    • Guernsey GBP £
    • Guinea GNF Fr
    • Guinea-Bissau XOF Fr
    • Guyana GYD $
    • Haiti USD $
    • Honduras HNL L
    • Hong Kong SAR HKD $
    • Hungary HUF Ft
    • Iceland ISK kr
    • India INR ₹
    • Indonesia IDR Rp
    • Iraq USD $
    • Ireland EUR €
    • Isle of Man GBP £
    • Israel ILS ₪
    • Italy EUR €
    • Jamaica JMD $
    • Japan JPY ¥
    • Jersey USD $
    • Jordan USD $
    • Kazakhstan KZT ₸
    • Kenya KES KSh
    • Kiribati USD $
    • Kosovo EUR €
    • Kuwait USD $
    • Kyrgyzstan KGS som
    • Laos LAK ₭
    • Latvia EUR €
    • Lebanon LBP ل.ل
    • Lesotho USD $
    • Liberia USD $
    • Libya USD $
    • Liechtenstein CHF CHF
    • Lithuania EUR €
    • Luxembourg EUR €
    • Macao SAR MOP P
    • Madagascar USD $
    • Malawi MWK MK
    • Malaysia MYR RM
    • Maldives MVR MVR
    • Mali XOF Fr
    • Malta EUR €
    • Martinique EUR €
    • Mauritania USD $
    • Mauritius MUR ₨
    • Mayotte EUR €
    • Mexico USD $
    • Moldova MDL L
    • Monaco EUR €
    • Mongolia MNT ₮
    • Montenegro EUR €
    • Montserrat XCD $
    • Morocco MAD د.م.
    • Mozambique USD $
    • Myanmar (Burma) MMK K
    • Namibia USD $
    • Nauru AUD $
    • Nepal NPR Rs.
    • Netherlands EUR €
    • New Caledonia XPF Fr
    • New Zealand NZD $
    • Nicaragua NIO C$
    • Niger XOF Fr
    • Nigeria NGN ₦
    • Niue NZD $
    • Norfolk Island AUD $
    • North Macedonia MKD ден
    • Norway USD $
    • Oman USD $
    • Pakistan PKR ₨
    • Palestinian Territories ILS ₪
    • Panama USD $
    • Papua New Guinea PGK K
    • Paraguay PYG ₲
    • Peru PEN S/
    • Philippines PHP ₱
    • Pitcairn Islands NZD $
    • Poland PLN zł
    • Portugal EUR €
    • Qatar QAR ر.ق
    • Réunion EUR €
    • Romania RON Lei
    • Russia USD $
    • Rwanda RWF FRw
    • Samoa WST T
    • San Marino EUR €
    • São Tomé & Príncipe STD Db
    • Saudi Arabia SAR ر.س
    • Senegal XOF Fr
    • Serbia RSD РСД
    • Seychelles USD $
    • Sierra Leone SLL Le
    • Singapore SGD $
    • Sint Maarten ANG ƒ
    • Slovakia EUR €
    • Slovenia EUR €
    • Solomon Islands SBD $
    • Somalia USD $
    • South Africa USD $
    • South Georgia & South Sandwich Islands GBP £
    • South Korea KRW ₩
    • South Sudan USD $
    • Spain EUR €
    • Sri Lanka LKR ₨
    • St. Barthélemy EUR €
    • St. Helena SHP £
    • St. Kitts & Nevis XCD $
    • St. Lucia XCD $
    • St. Martin EUR €
    • St. Pierre & Miquelon EUR €
    • St. Vincent & Grenadines XCD $
    • Sudan USD $
    • Suriname USD $
    • Svalbard & Jan Mayen USD $
    • Sweden SEK kr
    • Switzerland CHF CHF
    • Taiwan TWD $
    • Tajikistan TJS ЅМ
    • Tanzania TZS Sh
    • Thailand THB ฿
    • Timor-Leste USD $
    • Togo XOF Fr
    • Tokelau NZD $
    • Tonga TOP T$
    • Trinidad & Tobago TTD $
    • Tristan da Cunha GBP £
    • Tunisia USD $
    • Türkiye USD $
    • Turkmenistan USD $
    • Turks & Caicos Islands USD $
    • Tuvalu AUD $
    • U.S. Outlying Islands USD $
    • Uganda UGX USh
    • Ukraine UAH ₴
    • United Arab Emirates AED د.إ
    • United Kingdom GBP £
    • United States USD $
    • Uruguay UYU $U
    • Uzbekistan UZS so'm
    • Vanuatu VUV Vt
    • Vatican City EUR €
    • Venezuela USD $
    • Vietnam VND ₫
    • Wallis & Futuna XPF Fr
    • Western Sahara MAD د.م.
    • Yemen YER ﷼
    • Zambia USD $
    • Zimbabwe USD $

    Språk

    Språk
    Konto

    Handlekurven din er tom

    Har du en konto? Logg inn for å betale raskere.

    Fortsett å handle

    ← Guider om levetid og kosttilskudd

    Muscle Power Leaves Before Strength Does

    LongevityTraining10 min lesing Aug 9, 2026Oppdatert Aug 10, 2026

    Share

    Two diverging curves showing muscle power declining faster than force with age

    I denne guiden

      Share

      There is a dynamometer in your kitchen, and you have been sitting in it for years.

      The test is unglamorous enough to be insulting. Sit in an ordinary chair, cross your arms over your chest, and stand up and sit down as many times as you can in thirty seconds. No equipment, no lab, no subscription. Researchers in Toledo, Spain have been running a version of this on thousands of older adults, and when they turned the repetition counts into watts and looked at what happened to people afterwards, the chair turned out to know things.

      What interests me is not that the test predicts something. Plenty of cheap tests do. It is that the quantity it measures — power — is the one the fitness culture almost never talks about, while the quantity we all talk about, strength, is the one that holds up longest.

      An older woman rising from a wooden chair with her arms folded across her chest, in morning light
      Arms crossed, feet flat, up and down for thirty seconds. The protocol is this ordinary.

      Power falls at roughly twice the rate of force

      Muscle strength is how much force you can produce. Muscle power is force multiplied by the speed you produce it at — the physics of catching yourself on a stair, not the physics of a heavy shrug. They sound like the same virtue described twice. They age completely differently.

      A Belgian group followed 489 adults for a decade, testing knee extension at baseline and again ten years later, and separated the force component from the velocity component instead of collapsing both into one score. In the older adults, maximum power fell by about 2.2–2.4% per year. Force, in the same people, fell by about 1.09–1.27%. Power was draining out at roughly double the rate of the thing most of us train.

      The composition of the loss also shifted. In middle age, the early dent in power came mostly from force. Later, velocity joined in — a progressively blunted ability to produce force quickly. Which means two people can post the same one-rep max and be in genuinely different condition, because one of them can still express it in under a second and the other cannot.

      Ten-year longitudinal decline

      Annual loss in muscle power vs force, by age group (% per year)

      Youngpower −0.6%/yr
      Middle-agedforce −0.65 to −1.02%/yr
      Middle-agedpower −1.1 to −1.4%/yr
      Olderforce −1.09 to −1.27%/yr
      Olderpower −2.2 to −2.4%/yr
      Maximum powerForce

      Knee-extension data from Alcazar et al., Journal of Cachexia, Sarcopenia and Muscle 2023 (n = 489, tested 2002–2004 and again 2012–2015). Every reported figure is printed in its label; where the paper gives a range, the bar width uses the midpoint of that range. Knee extension only — one joint, not the whole body.

      Why the grip test misses it

      We have written admiringly about grip strength, and I still think it earns its place as a five-second proxy for how the whole body is holding up. But it is worth reporting the study that argues against us.

      Researchers looked at older adults around the age of ninety and asked which measurement best explained who was still physically independent. They put sit-to-stand power, handgrip strength, physical activity and sedentary time into the same model. Sit-to-stand power carried a standardised coefficient of 0.45. Handgrip came in at −0.02 — statistically indistinguishable from contributing nothing once power was in the room. Sedentary time (−0.28) mattered more than grip did.

      That is a cross-sectional analysis in a cohort near ninety, so it describes a snapshot rather than a sequence, and grip may well be measuring something different and still useful earlier in life. But the direction is uncomfortable and worth sitting with: a squeeze is a slow, isometric act. It samples force with the velocity term set to zero. It is, almost by design, blind to the thing that erodes first.

      What low power travels with — in three honest tiers

      The evidence here is real but stacked, and the tiers are not equally strong. Worth separating them rather than quoting the scariest number.

      Cross-sectional, so the largest numbers. Working from 1,475 adults aged 65–98 in Toledo, researchers derived cut-offs for low relative sit-to-stand power: below 2.53 W/kg for men, below 2.01 W/kg for women. People under those lines were more likely to be frail (odds ratio 4.4 in men, 5.2 in women) and to have slow habitual gait speed (3.4 and 6.1). Large odds — but measured at the same moment, so they cannot tell you which came first.

      Prospective, so smaller and more believable. Following 839 of the same adults for about five years, low power was associated with later development of frailty (OR 2.51), difficulty with basic daily activities (1.70), difficulty with instrumental ones (1.79), and increased medication use (1.51). Note what did not reach significance: cognitive impairment (1.38), depression (1.29), and frailty measured by a second definition. The signal is about physical function specifically. It is not a general index of everything.

      Mortality. In the 1,876-person analysis, men below the power threshold had a 57% higher risk of death from any cause and women more than double the risk over roughly nine years. Falls and fractures also clustered below the line — but those were history, recorded at the same visit as the test, which is a different and weaker kind of finding than the prospective ones. More than half the cohort sat below the cut-off for their sex.

      All of it is association. The most obvious rival explanation is that early illness makes people slower out of a chair, rather than slowness making them ill, and no observational study of this design can rule that out. The five-year study also lost its frailer participants to attrition, which biases toward the healthy. Read these numbers as a signal about the body's current condition, not as a forecast.

      The velocity term is trainable, which is the whole point

      A risk marker you can't move is trivia. This one moves.

      A meta-analysis pooled fourteen trials of high-speed resistance training in independent older adults aged 69–82 — 408 participants randomised. The protocols were remarkably consistent: loads of 40–80% of one-rep max, the lifting phase performed as fast as possible (under a second), the lowering phase controlled over two to three seconds, three sessions a week for eight to sixteen weeks. Pooled effect on neuromuscular function was moderate (SMD 0.70, 95% CI 0.24–1.15); on physical function, 0.55. The authors concluded that ten weeks or more, three times a week, is where the reliable gains showed up.

      Honesty about that evidence: twelve of the fourteen studies were rated low methodological quality, only one was pre-registered, the samples were small, heterogeneity was moderate to substantial, and nobody followed participants long enough to know whether the gains stick. This is a promising and coherent literature, not a settled one.

      Intent is what you change, not the weight

      Here is the part that surprised me when I first understood it, and the part worth taking into this week's training.

      Power training is not a different exercise list. It is the same squat, press and row performed with a different intention: move the load fast on the way up, control it on the way down. The load itself sits in a moderate range — 40–80% of your maximum, not the grinding heavy end, because you cannot accelerate something you can barely lift. If your gym time is a slow, controlled, respectable grind through every repetition, you are training force and leaving velocity untouched.

      The everyday version needs no gym at all. Stand up out of the chair fast; sit back down slowly. Take the stairs two at a time where it is safe. Carry the shopping and set it down deliberately. These sound like nothing, and they are structurally the same instruction the trials gave: brief, deliberate, fast concentric effort, repeated often enough to matter.

      One caution the enthusiasm tends to skip. Fast movement is a skill before it is a stimulus, and connective tissue adapts on a slower clock than muscle does. If you are coming back from a long gap, add speed gradually and to movements you already own, and if you have joint problems, a balance issue, or any cardiac history, get advice from a clinician before you start accelerating loads.

      Practical

      Testing yourself, and what the chair cannot tell you

      How to run the 30-second version
      A firm chair of ordinary height, no arms used. Cross your arms over your chest, feet flat. Stand fully upright and sit fully back down, as many times as you can in thirty seconds. Same chair, same shoes, same time of day whenever you repeat it — the comparison is only worth as much as its consistency. If you feel unsteady, do it with a wall or a second person beside you, or skip it.
      Why we suggest counting reps, not watts
      The published thresholds (2.53 W/kg for men, 2.01 for women) come from an equation that converts body mass, height and repetition count into watts per kilogram — and they were derived in adults aged 65–98. They are not a benchmark for a 45-year-old, and a number you compute at home is not a clinical result. Your own repetition count, under fixed conditions, retested every few months, is the honest instrument.
      What would make this a doctor's question
      A clear drop in what you can do rather than a slow drift, new unsteadiness or a fall, dizziness on standing, or breathlessness and chest discomfort during ordinary effort. No test you run at home diagnoses anything, and this one is no exception — it describes today's function, nothing more.

      Method follows the 30-second sit-to-stand protocol used in the Toledo Study for Healthy Aging; thresholds from Garcia-Aguirre et al. 2025. Educational information, not medical advice.

      Measure the trend, not the digit

      The reason this test appeals to me is the same reason we keep arguing that a sensor is only as good as the question you ask it. A repetition count is crude. It is also yours, repeatable, free, and sensitive to something that is genuinely changing underneath.

      Do it once and you have a number of no particular meaning. Do it in February, May and September under the same conditions and you have a trend line for a physical capacity that most people never look at until it announces itself in a stumble. That is the same logic behind reading your resting heart rate and HRV as drift against your own baseline rather than against a population chart, and behind treating a longevity protocol as a loop — measure, act, re-measure — instead of a list.

      Use numbers to correct fantasy, not to replace experience. The fantasy here is that strength is the whole story and that a respectable deadlift means the machinery is intact. The experience is standing up from a low sofa and noticing, for the first time, that you thought about it first.

      The bottom line

      Power — force expressed quickly — declines about twice as fast as force does, starts earlier than most people assume, and appears to track physical independence better than the grip test we all reach for. Low sit-to-stand power is associated with frailty, functional difficulty and higher mortality in adults over 65, though the evidence is observational and the opposite explanation cannot be excluded. The trainable variable is not the weight but the intent: moderate loads moved fast on the way up, controlled on the way down, three times a week, judged over months. Test yourself in a chair a few times a year, and read the direction rather than the digit. If you are tracking training load and recovery alongside it, the Agen Band and the physical performance range are there for the parts a chair can't see — but the chair remains the cheapest honest instrument in the house.

      Kilder

      1. Alcazar J, Rodriguez-Lopez C, Delecluse C, Thomis M, Van Roie E. Ten-year longitudinal changes in muscle power, force, and velocity in young, middle-aged, and older adults. Journal of Cachexia, Sarcopenia and Muscle 2023;14(2):1019-1032. https://doi.org/10.1002/jcsm.13184
      2. Hetherington-Rauth M, Magalhaes JP, Alcazar J, et al. Relative Sit-to-Stand Muscle Power Predicts an Older Adult's Physical Independence at Age of 90 Yrs Beyond That of Relative Handgrip Strength, Physical Activity, and Sedentary Time. American Journal of Physical Medicine & Rehabilitation 2022;101(11):995-1000. https://doi.org/10.1097/PHM.0000000000001945
      3. Garcia-Aguirre M, et al. Cut-Off Points for Low Relative 30-s Sit-to-Stand Power and Their Associations With Adverse Health Conditions. Journal of Cachexia, Sarcopenia and Muscle 2025;16(1):e13676. https://doi.org/10.1002/jcsm.13676
      4. Garcia-Aguirre M, Baltasar-Fernandez I, Alcazar J, et al. Low Relative Sit-to-Stand Power Is Associated With the Development of Adverse Health Outcomes: A 5-Year Longitudinal Study. Journal of Cachexia, Sarcopenia and Muscle 2025;16(3):e13852. https://doi.org/10.1002/jcsm.13852
      5. Low relative sit-to-stand power is associated with history of falls and fractures, prospective hospitalization, and all-cause mortality in older adults from the Toledo Study for Healthy Aging. Journal of Sport and Health Science 2026;15. https://doi.org/10.1016/j.jshs.2025.101080
      6. Martins AD, Fernandes O, Pereira A, et al. The Effects of High-Speed Resistance Training on Health Outcomes in Independent Older Adults: A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health 2022;19(9):5390. https://doi.org/10.3390/ijerph19095390

      Om forfatteren

      Vladimir Sitnikov is the founder of Agen. He writes about longevity, measurement, and building a wellbeing system that adapts to you.

      Denne artikkelen er kun for opplæringsformål og er ikke medisinsk rådgivning. Disse påstandene er ikke vurdert av Food and Drug Administration. Agen-produkter er ikke ment å diagnostisere, behandle, kurere eller forebygge noen sykdom. Rådfør deg med legen din før du starter med et kosttilskudd, spesielt hvis du er gravid, ammer eller bruker medisiner.

      Fortsett å lese

      D-vitamin og magefett: overskriften snudde pilen feil Longevity · 10 min lesing Seks etasjer om dagen: hva trappestudien egentlig målte Training · 9 min lesing Gjør en følelse av mening at du faktisk lever lenger? Longevity · 10 min lesing

      Hold protokollen din ærlig.

      Hvert Agen-tilskudd er evidensvurdert på samme måte som disse guidene er skrevet. Se hva forskningen støtter.

      Kjøp tilskudd
      Agen Com Pte Ltd

      Ha kontroll på helsen din og støtt langsiktig velvære ved å forene tilskudd, smarte enheter og AI-veiledning i ett system.

      Naviger

      • App
      • Robot
      • Band
      • CAROL Bike
      • Kosttilskudd
      • FAQ
      • Journal
      • Karriere
      • Trust Center
      • Kontakt

      Informasjon

      • Personvernerklæring
      • Vilkår for bruk
      • Fraktpolicy
      • Retur og refusjon
      • Betalingspolicy
      • Garantipolicy

      Kontakt

      Agen Com Pte. Ltd.

      8 Temasek Boulevard #30-01/02 Suntec Tower 3, Singapore 038988

      UEN: 202421957H

      info@agen.com

      +65 8422 1101

      Disse påstandene er ikke vurdert av Food and Drug Administration. Dette produktet er ikke ment å diagnostisere, behandle, kurere eller forebygge noen sykdom. Som med alle kosttilskudd bør du informere helsepersonellet ditt om bruken av dette produktet.

      Betalingsmåter
      • American Express
      • Apple Pay
      • Google Pay
      • Mastercard
      • Shop Pay
      • Union Pay
      • Visa

      Opphavsrett © 2026 Agen Com Pte. Ltd.

      Søk

      Produkter

      • Agen Band
        Agen Band biomarker wearable, front view Agen Band biomarker wearable — supplement facts and ingredients

        Agen Band

        Vanlig pris  $149.00 Rabattert pris  $99.00
      • Agen Robot og startpakke
        Agen Robot supplement dispenser on a kitchen counter Agen Robot supplement dispenser — supplement facts and ingredients

        Agen Robot og startpakke

        $399.00
      • Ashwagandha
        Agen Ashwagandha supplement, front of bottle Agen Ashwagandha bottle on a travertine counter in soft morning light

        Ashwagandha

        $15.00
      • Astaksantin
        Agen Astaxanthin supplement, front of bottle

        Astaksantin

        $6.00

      Du er med.

      10%-koden din står nedenfor – og er også på vei til innboksen din.

      READY10
      Fri frakt fra 100 $ — 150 $ internasjonalt

      10% på din første ordre

      Kosttilskudd dosert for kroppen din — ikke for gjennomsnittet. Fri frakt fra 100 $ — 150 $ internasjonalt.

      Kode med en gang · Ingen spam · Meld deg av når som helst

      Ved å melde deg på godtar du å motta markedsføringse-poster. Se vår personvernerklæring og vilkår.